Celldex Therapeutics, Inc vs. Intellia Therapeutics, Inc
Celldex Therapeutics, Inc and Intellia Therapeutics, Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CLDX | NTLA | |
|---|---|---|
| Market Cap | $2.35 billion | $1.75 billion |
CLDX leads on 1 of 1 size & scale factors.
Risk & Sentiment
| CLDX | NTLA | |
|---|---|---|
| Short Interest | 9.28% | 2.43% |
NTLA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, NTLA overview, NTLA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.